Taken together, these findings indicate that TRAIL-ATNCIL4rP, by virtue of its enhanced stability, higher affinity for the TRAIL receptor, and stronger apoptosis-promoting action, produces potent tumor cell apoptosis and thus successively inhibits tumor growth. The gene discussed is TNFSF10; the disease is neoplasm.